Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Cerebrospinal fluid flow increases from newborn to adult stages.

Di Palma C, Goulay R, Chagnot S, Martinez De Lizarrondo S, Anfray A, Salaun JP, Maubert E, Lechapt-Zalcman E, Andreiuolo F, Gakuba C, Emery E, Vivien D, Gauberti M, Gaberel T.

Dev Neurobiol. 2018 Sep;78(9):851-858. doi: 10.1002/dneu.22622. Epub 2018 Aug 2.

PMID:
30027587
2.

Impact of Bradykinin Generation During Thrombolysis in Ischemic Stroke.

Gauberti M, Potzeha F, Vivien D, Martinez de Lizarrondo S.

Front Med (Lausanne). 2018 Jul 3;5:195. doi: 10.3389/fmed.2018.00195. eCollection 2018. Review.

3.

Erratum to: Molecular Magnetic Resonance Imaging (mMRI).

Gauberti M, Fournier AP, Vivien D, Martinez de Lizarrondo S.

Methods Mol Biol. 2018;1718:E1. doi: 10.1007/978-1-4939-7531-0_27. No abstract available.

PMID:
29605882
4.

Modification of apparent intracerebral hematoma volume on T2-weighted images during normobaric oxygen therapy may contribute to false diagnosis.

Goulay R, Drieu A, Di Palma C, Pro-Sistiaga P, Delcroix N, Chazalviel L, Saulnier R, Gakuba C, Goursaud S, Young AR, Gauberti M, Orset C, Emery E, Vivien D, Gaberel T.

J Clin Neurosci. 2018 Jun;52:105-108. doi: 10.1016/j.jocn.2018.01.046. Epub 2018 Mar 21.

PMID:
29571939
5.

Brain-released alarmins and stress response synergize in accelerating atherosclerosis progression after stroke.

Roth S, Singh V, Tiedt S, Schindler L, Huber G, Geerlof A, Antoine DJ, Anfray A, Orset C, Gauberti M, Fournier A, Holdt LM, Harris HE, Engelhardt B, Bianchi ME, Vivien D, Haffner C, Bernhagen J, Dichgans M, Liesz A.

Sci Transl Med. 2018 Mar 14;10(432). pii: eaao1313. doi: 10.1126/scitranslmed.aao1313.

PMID:
29540615
6.

Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System.

Gauberti M, Fournier AP, Docagne F, Vivien D, Martinez de Lizarrondo S.

Theranostics. 2018 Feb 2;8(5):1195-1212. doi: 10.7150/thno.22662. eCollection 2018. Review.

7.

Reduced spinal cord parenchymal cerebrospinal fluid circulation in experimental autoimmune encephalomyelitis.

Fournier AP, Gauberti M, Quenault A, Vivien D, Macrez R, Docagne F.

J Cereb Blood Flow Metab. 2018 Jan 29:271678X18754732. doi: 10.1177/0271678X18754732. [Epub ahead of print]

PMID:
29376456
8.

General Anesthesia Inhibits the Activity of the "Glymphatic System".

Gakuba C, Gaberel T, Goursaud S, Bourges J, Di Palma C, Quenault A, Martinez de Lizarrondo S, Vivien D, Gauberti M.

Theranostics. 2018 Jan 1;8(3):710-722. doi: 10.7150/thno.19154. eCollection 2018.

9.

Molecular Magnetic Resonance Imaging (mMRI).

Gauberti M, Fournier AP, Vivien D, Martinez de Lizarrondo S.

Methods Mol Biol. 2018;1718:315-327. doi: 10.1007/978-1-4939-7531-0_19. Erratum in: Methods Mol Biol. 2018;1718:E1. P Fournier, Antoine [corrected to Fournier, Antoine P].

PMID:
29341017
10.

Vascular Tissue-Type Plasminogen Activator Promotes Intracranial Aneurysm Formation.

Labeyrie PE, Goulay R, Martinez de Lizarrondo S, Hébert M, Gauberti M, Maubert E, Delaunay B, Gory B, Signorelli F, Turjman F, Touzé E, Courthéoux P, Vivien D, Orset C.

Stroke. 2017 Sep;48(9):2574-2582. doi: 10.1161/STROKEAHA.117.017305. Epub 2017 Jul 28.

PMID:
28754830
11.

Prediction of disease activity in models of multiple sclerosis by molecular magnetic resonance imaging of P-selectin.

Fournier AP, Quenault A, Martinez de Lizarrondo S, Gauberti M, Defer G, Vivien D, Docagne F, Macrez R.

Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):6116-6121. doi: 10.1073/pnas.1619424114. Epub 2017 May 22.

12.

Subarachnoid Hemorrhage Severely Impairs Brain Parenchymal Cerebrospinal Fluid Circulation in Nonhuman Primate.

Goulay R, Flament J, Gauberti M, Naveau M, Pasquet N, Gakuba C, Emery E, Hantraye P, Vivien D, Aron-Badin R, Gaberel T.

Stroke. 2017 Aug;48(8):2301-2305. doi: 10.1161/STROKEAHA.117.017014. Epub 2017 May 19.

PMID:
28526764
13.

Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.

Martinez de Lizarrondo S, Gakuba C, Herbig BA, Repessé Y, Ali C, Denis CV, Lenting PJ, Touzé E, Diamond SL, Vivien D, Gauberti M.

Circulation. 2017 Aug 15;136(7):646-660. doi: 10.1161/CIRCULATIONAHA.117.027290. Epub 2017 May 9.

14.

Molecular magnetic resonance imaging discloses endothelial activation after transient ischaemic attack.

Quenault A, Martinez de Lizarrondo S, Etard O, Gauberti M, Orset C, Haelewyn B, Segal HC, Rothwell PM, Vivien D, Touzé E, Ali C.

Brain. 2017 Jan;140(1):146-157. doi: 10.1093/brain/aww260. Epub 2016 Nov 8.

15.

Valproic acid: a relevant thromboprophylactic strategy?

Martinez de Lizarrondo S, Gauberti M, Vivien D.

J Thromb Haemost. 2016 Dec;14(12):2493-2495. doi: 10.1111/jth.13528. Epub 2016 Nov 17. No abstract available.

PMID:
27709777
16.

Hyperfibrinolysis increases blood-brain barrier permeability by a plasmin- and bradykinin-dependent mechanism.

Marcos-Contreras OA, Martinez de Lizarrondo S, Bardou I, Orset C, Pruvost M, Anfray A, Frigout Y, Hommet Y, Lebouvier L, Montaner J, Vivien D, Gauberti M.

Blood. 2016 Nov 17;128(20):2423-2434. Epub 2016 Aug 16.

17.

Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke: A Retrospective Pooled Analysis.

Orset C, Haelewyn B, Allan SM, Ansar S, Campos F, Cho TH, Durand A, El Amki M, Fatar M, Garcia-Yébenes I, Gauberti M, Grudzenski S, Lizasoain I, Lo E, Macrez R, Margaill I, Maysami S, Meairs S, Nighoghossian N, Orbe J, Paramo JA, Parienti JJ, Rothwell NJ, Rubio M, Waeber C, Young AR, Touzé E, Vivien D.

Stroke. 2016 May;47(5):1312-1318. doi: 10.1161/STROKEAHA.116.012238. Epub 2016 Mar 31.

18.

Nano-zymography Using Laser-Scanning Confocal Microscopy Unmasks Proteolytic Activity of Cell-Derived Microparticles.

Briens A, Gauberti M, Parcq J, Montaner J, Vivien D, Martinez de Lizarrondo S.

Theranostics. 2016 Mar 2;6(5):610-26. doi: 10.7150/thno.13757. eCollection 2016.

19.

Unmasking Silent Endothelial Activation in the Cardiovascular System Using Molecular Magnetic Resonance Imaging.

Belliere J, Martinez de Lizarrondo S, Choudhury RP, Quenault A, Le Béhot A, Delage C, Chauveau D, Schanstra JP, Bascands JL, Vivien D, Gauberti M.

Theranostics. 2015 Aug 8;5(11):1187-202. doi: 10.7150/thno.11835. eCollection 2015.

20.

Impact of alcohol consumption on the outcome of ischemic stroke and thrombolysis: role of the hepatic clearance of tissue-type plasminogen activator.

Lemarchand E, Gauberti M, Martinez de Lizarrondo S, Villain H, Repessé Y, Montagne A, Vivien D, Ali C, Rubio M.

Stroke. 2015 Jun;46(6):1641-50. doi: 10.1161/STROKEAHA.114.007143. Epub 2015 Apr 28.

PMID:
25922513
21.

Crucial role of the protein corona for the specific targeting of nanoparticles.

Mahmoudi M, Sheibani S, Milani AS, Rezaee F, Gauberti M, Dinarvand R, Vali H.

Nanomedicine (Lond). 2015 Jan;10(2):215-26. doi: 10.2217/nnm.14.69.

PMID:
25600967
22.

Letter by Gauberti and Vivien regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice".

Gauberti M, Vivien D.

Stroke. 2015 Feb;46(2):e50-1. doi: 10.1161/STROKEAHA.114.008071. Epub 2015 Jan 13. No abstract available.

PMID:
25586834
23.

Molecular magnetic resonance imaging of brain-immune interactions.

Gauberti M, Montagne A, Quenault A, Vivien D.

Front Cell Neurosci. 2014 Nov 27;8:389. doi: 10.3389/fncel.2014.00389. eCollection 2014. Review.

24.

Letter by Gaberel et al regarding article, "fibrinolysis for intraventricular hemorrhage: an updated meta-analysis and systematic review of the literature".

Gaberel T, Gakuba C, Gauberti M.

Stroke. 2014 Nov;45(11):e235. doi: 10.1161/STROKEAHA.114.007150. Epub 2014 Sep 30. No abstract available.

PMID:
25270627
25.

Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis?

Gaberel T, Gakuba C, Goulay R, Martinez De Lizarrondo S, Hanouz JL, Emery E, Touze E, Vivien D, Gauberti M.

Stroke. 2014 Oct;45(10):3092-6. doi: 10.1161/STROKEAHA.114.006617. Epub 2014 Sep 4.

PMID:
25190438
26.

Urokinase versus Alteplase for intraventricular hemorrhage fibrinolysis.

Gaberel T, Montagne A, Lesept F, Gauberti M, Lemarchand E, Orset C, Goulay R, Bertrand T, Emery E, Vivien D.

Neuropharmacology. 2014 Oct;85:158-65. doi: 10.1016/j.neuropharm.2014.05.001. Epub 2014 May 15.

PMID:
24846802
27.

tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury.

Lemarchant S, Pruvost M, Hébert M, Gauberti M, Hommet Y, Briens A, Maubert E, Gueye Y, Féron F, Petite D, Mersel M, do Rego JC, Vaudry H, Koistinaho J, Ali C, Agin V, Emery E, Vivien D.

Neurobiol Dis. 2014 Jun;66:28-42. doi: 10.1016/j.nbd.2014.02.005. Epub 2014 Feb 25.

PMID:
24576594
28.

GpIbα-VWF blockade restores vessel patency by dissolving platelet aggregates formed under very high shear rate in mice.

Le Behot A, Gauberti M, Martinez De Lizarrondo S, Montagne A, Lemarchand E, Repesse Y, Guillou S, Denis CV, Maubert E, Orset C, Vivien D.

Blood. 2014 May 22;123(21):3354-63. doi: 10.1182/blood-2013-12-543074. Epub 2014 Feb 19.

29.

Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates.

Gauberti M, Martinez de Lizarrondo S, Orset C, Vivien D.

J Thromb Haemost. 2014;12(3):409-14. doi: 10.1111/jth.12487.

30.

Intracerebral hematomas disappear on T2*-weighted images during normobaric oxygen therapy.

Gaberel T, Gakuba C, Hebert M, Montagne A, Agin V, Rubio M, Emery E, Vivien D, Gauberti M.

Stroke. 2013 Dec;44(12):3482-9. doi: 10.1161/STROKEAHA.113.002045. Epub 2013 Oct 8.

PMID:
24105700
31.

Endovascular treatment for acute ischemic stroke.

Gakuba C, Gauberti M, Vivien D.

N Engl J Med. 2013 Jun 20;368(25):2430-1. doi: 10.1056/NEJMc1304759. No abstract available.

PMID:
23782184
32.

Ultra-sensitive molecular MRI of vascular cell adhesion molecule-1 reveals a dynamic inflammatory penumbra after strokes.

Gauberti M, Montagne A, Marcos-Contreras OA, Le Béhot A, Maubert E, Vivien D.

Stroke. 2013 Jul;44(7):1988-96. doi: 10.1161/STROKEAHA.111.000544. Epub 2013 Jun 6.

PMID:
23743972
33.

Potential of olfactory ensheathing cells from different sources for spinal cord repair.

Mayeur A, Duclos C, Honoré A, Gauberti M, Drouot L, do Rego JC, Bon-Mardion N, Jean L, Vérin E, Emery E, Lemarchant S, Vivien D, Boyer O, Marie JP, Guérout N.

PLoS One. 2013 Apr 24;8(4):e62860. doi: 10.1371/journal.pone.0062860. Print 2013.

34.

Immunotherapy blocking the tissue plasminogen activator-dependent activation of N-methyl-D-aspartate glutamate receptors improves hemorrhagic stroke outcome.

Gaberel T, Macrez R, Gauberti M, Montagne A, Hebert M, Petersen KU, Touze E, Agin V, Emery E, Ali C, Vivien D.

Neuropharmacology. 2013 Apr;67:267-71. doi: 10.1016/j.neuropharm.2012.11.023. Epub 2012 Dec 3.

PMID:
23219658
35.

Memantine improves safety of thrombolysis for stroke.

Montagne A, Hébert M, Jullienne A, Lesept F, Le Béhot A, Louessard M, Gauberti M, Orset C, Ali C, Agin V, Maubert E, Vivien D.

Stroke. 2012 Oct;43(10):2774-81. Epub 2012 Aug 9.

PMID:
22879098
36.

Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders.

Montagne A, Gauberti M, Macrez R, Jullienne A, Briens A, Raynaud JS, Louin G, Buisson A, Haelewyn B, Docagne F, Defer G, Vivien D, Maubert E.

Neuroimage. 2012 Nov 1;63(2):760-70. doi: 10.1016/j.neuroimage.2012.07.018. Epub 2012 Jul 17.

PMID:
22813950
37.

Thrombotic stroke in the anesthetized monkey (Macaca mulatta): characterization by MRI--a pilot study.

Gauberti M, Obiang P, Guedin P, Balossier A, Gakuba C, Diependaele AS, Chazalviel L, Vivien D, Young AR, Agin V, Orset C.

Cerebrovasc Dis. 2012;33(4):329-39. doi: 10.1159/000335309. Epub 2012 Feb 16.

PMID:
22343114
38.

Absence of TI-VAMP/Vamp7 leads to increased anxiety in mice.

Danglot L, Zylbersztejn K, Petkovic M, Gauberti M, Meziane H, Combe R, Champy MF, Birling MC, Pavlovic G, Bizot JC, Trovero F, Della Ragione F, Proux-Gillardeaux V, Sorg T, Vivien D, D'Esposito M, Galli T.

J Neurosci. 2012 Feb 8;32(6):1962-8. doi: 10.1523/JNEUROSCI.4436-11.2012.

39.

Impact of tissue plasminogen activator on the neurovascular unit: from clinical data to experimental evidence.

Vivien D, Gauberti M, Montagne A, Defer G, Touzé E.

J Cereb Blood Flow Metab. 2011 Nov;31(11):2119-34. doi: 10.1038/jcbfm.2011.127. Epub 2011 Aug 31. Review.

40.

Preclinical evidence toward the use of ketamine for recombinant tissue-type plasminogen activator-mediated thrombolysis under anesthesia or sedation.

Gakuba C, Gauberti M, Mazighi M, Defer G, Hanouz JL, Vivien D.

Stroke. 2011 Oct;42(10):2947-9. doi: 10.1161/STROKEAHA.111.620468. Epub 2011 Aug 4.

PMID:
21817137
41.

Antibodies preventing the interaction of tissue-type plasminogen activator with N-methyl-D-aspartate receptors reduce stroke damages and extend the therapeutic window of thrombolysis.

Macrez R, Obiang P, Gauberti M, Roussel B, Baron A, Parcq J, Cassé F, Hommet Y, Orset C, Agin V, Bezin L, Berrocoso TG, Petersen KU, Montaner J, Maubert E, Vivien D, Ali C.

Stroke. 2011 Aug;42(8):2315-22. doi: 10.1161/STROKEAHA.110.606293. Epub 2011 Jun 16.

PMID:
21680906
42.

Tissue plasminogen activator prevents white matter damage following stroke.

Correa F, Gauberti M, Parcq J, Macrez R, Hommet Y, Obiang P, Hernangómez M, Montagne A, Liot G, Guaza C, Maubert E, Ali C, Vivien D, Docagne F.

J Exp Med. 2011 Jun 6;208(6):1229-42. doi: 10.1084/jem.20101880. Epub 2011 May 16.

43.

[Cerebral ischemia (2), How to neutralize the neurotoxic effects of tPA].

Vivien D, Gauberti M, Guedin P, Anglés-Cano E; STROKAVENIR.

Med Sci (Paris). 2009 Oct;25(10):855-7. doi: 10.1051/medsci/20092510855. French. No abstract available.

Supplemental Content

Loading ...
Support Center